HiCisco (002653.SZ): Received IND application for innovative drug HSK60002 tablets “Notice of Acceptance”

Zhitongcaijing · 3d ago

Zhitong Finance App News, HiCisco (002653.SZ) issued an announcement. The company recently received the “Notice of Acceptance” issued by the State Drug Administration, and the application for registration of domestically produced drugs intended for use in inflammatory diseases, the innovative drug HSK60002 tablets independently developed by the company was accepted.

According to reports, pre-clinical research data showed that HSK60002 showed significant pharmacodynamic activity in related animal models, and the mechanism of action was clear. Based on existing results, HSK60002 has clear development value and good transformation prospects, and is expected to provide clinical patients with an efficient and safe novel treatment option.